Improved efficacy of a licensed acellular pertussis vaccine, reformulated in an adjuvant emulsion of liposomes in oil, in a murine model

Clinical and Vaccine Immunology

Volumn 14, Issue 10, 2007, Pages 1381-1383

  Mansour, Marc ^a   Brown, Robert G ^a   Morris, Annette ^a   Smith, Bruce ^a   Halperin, Scott A ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; QUADRACEL; UNCLASSIFIED DRUG; VACCIMAX; VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG FORMULATION; EMULSION; FEMALE; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; SINGLE DRUG DOSE; STUDENT T TEST; TREATMENT OUTCOME; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BORDETELLA PERTUSSIS; DRUG APPROVAL; DRUG DELIVERY SYSTEMS; EMULSIONS; FEMALE; IMMUNIZATION SCHEDULE; LIPOSOMES; MICE; MICE, INBRED BALB C; MODELS, ANIMAL; OILS; PERTUSSIS VACCINE; VACCINES, ACELLULAR;

EID: 35548969832     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00143-07     Document Type: Article

References (9)

1. Brown, R. G., W. D. Bowen, J. D. Eddington, W. C. Kimmins, M. Mezei, J. L. Parsons, and B. Pohajdak. 1997. Temporal trends in antibody production in captive grey, harp and hooded seals to a single administration immunocontraceptive vaccine. J. Reprod. Immunol. 35:53-64.
2. Centers for Disease Control and Prevention. 1995. Pertussis-United States, Jan. 1992 to June 1995. Morb. Mortal. Wkly. Rep. 44:525-529.
3. Daftarian, P., M. Mansour, A. C. Benoit, B. Pohajdak, D. W. Hoskin, R. G. Brown, and W. M. Kast. 2006. Eradication of established HPV 16-expressing tumors by a single administration of a vaccine composed of a liposome-encapsulated CTL-T helper fusion peptide in a water-in-oil emulsion. Vaccine 24:5235-5244.
4. Halperin, S. A., S. A. Heifetz, and A. Kasina. 1988. Experimental respiratory infection with Bordetella pertussis in mice: comparison of two methods. Clin. Investig. Med. 11:297-303.
5. Lee, S. F., S. A. Halperin, D. F. Salloum, A. MacMillian, and A. Morris. 2003. Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimera protein. Infect. Immun. 71:2272-2275.
6. Mills, K. H. G. 2001. Immunity to B. pertussis. Microbes Infect. 3:655-677.
7. Pichichero, M. E., L. M. DeTora, and D. R. Johnson. 2006. An adolescent and adult formulation combined tetanus, diphtheria and five-component pertussis vaccine. Expert Rev. Vaccines 5:175-187.
8. Ulmer, J. B., and M. A. Liu. 2002. Ethical issues for vaccines and immunization. Nat. Rev. Immunol. 2:291-296.
9. World Health Organization. 1999. Pertussis vaccines. Wkly. Epidemiol. Rec. 74:137-144.